Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) EPS (Basic) (2024 - 2026)

Updated

Translational Development Acquisition's EPS (Basic) came in at $0.04 for Q2 2026, down 40.6% from $0.07 a year earlier and down 27.6% from the prior quarter.

Analysis

Translational Development Acquisition (TDACU) EPS (Basic) (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Translational Development Acquisition reported EPS (Basic) of $0.26, up 85.7% year-over-year; for FY2025, it was $0.37.

  • Going back by year, EPS (Basic) was -$0.01 in FY2024 and $5,994 in FY2023.
  • The Q2 2026 figure represents the lowest quarterly EPS (Basic) since Q4 2024.
  • Business Quant data shows TDACU's EPS (Basic) at $0.06 (Q1 2026), $0.09 (Q4 2025) and $0.08 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.04
Mar 31, 2026 0.06
Dec 31, 2025 0.09
Sep 30, 2025 0.08
Jun 30, 2025 0.07
Mar 31, 2025 0.07
Dec 31, 2024 0.00
Sep 30, 2024 -0.02
Jun 30, 2024 0.00
API Access

Translational Development Acquisition EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=TDACU&period=max&api_key=YOUR_API_KEY